What are the best healthcare stocks in 2026?

Based on AI conviction analysis, the top best healthcare stocks include RIGL, DGX, IQV, JNJ, ABT. Each stock is scored on quality, fair value, and risk-reward asymmetry.

How are best healthcare stocks ranked?

Stocks are ranked by AI conviction score (1-10) using fundamental analysis: DCF valuation, earnings quality, Monte Carlo scenarios, and risk-reward asymmetry. Each stock also receives a quality grade (A-F) and a rating from Strong Buy to Avoid.

All categories

Best Healthcare Stocks

Top healthcare and pharma stocks ranked by conviction score, fair value, and quality. Defensive names with durable demand.

85 stocks

#	Ticker	Company	Rating	Convex Score	Fair Value	Upside	Quality
1	RIGL	Rigel Pharmaceuticals, Inc.	Score A+	10/10	$55	+31.9%	A	View
2	DGX	Quest Diagnostics Incorporated	Score A	10/10	$345	+45.1%	B	View
3	IQV	IQVIA Holdings Inc.	Score A	10/10	$348	+43.7%	C	View
4	JNJ	Johnson & Johnson	Score A	10/10	$282	+7.7%	A	View
5	ABT	Abbott Laboratories	Score A	10/10	$92	-15.4%	B	View
6	SYK	Stryker Corporation	Score A	10/10	$486	+40.7%	B	View
7	BIO	Bio-Rad Laboratories, Inc.	Score A	10/10	$355	+0.0%	C	View
8	BIIB	Biogen Inc.	Score A	10/10	$269	+30.0%	B	View
9	COO	The Cooper Companies, Inc.	Score A	10/10	$93	+22.5%	C	View
10	BMY	Bristol-Myers Squibb Company	Score A	10/10	$71	+9.2%	B	View
11	BSX	Boston Scientific Corporation	Score A	10/10	$92	+82.1%	B	View
12	DHR	Danaher Corporation	Score A	10/10	$256	+22.1%	C	View
13	CI	Cigna Corporation	Score A	10/10	$524	+88.3%	C	View
14	DXCM	DexCom, Inc.	Score A+	10/10	$103	+17.9%	A	View
15	COR	Cencora, Inc.	Score A	10/10	$553	+70.2%	B	View
16	GILD	Gilead Sciences, Inc.	Score A	10/10	$162	+21.8%	C	View
17	GEHC	GE HealthCare Technologies Inc.	Score A	10/10	$95	+30.0%	B	View
18	EW	Edwards Lifesciences Corporation	Score C	10/10	$71	-22.5%	A	View
19	HOLX	Hologic, Inc.	Score A	10/10	$93	+22.3%	C	View
20	HSIC	Henry Schein, Inc.	Score A	10/10	$128	+45.3%	C	View
21	IDXX	IDEXX Laboratories, Inc.	Score B	10/10	$494	-17.0%	A	View
22	LLY	Eli Lilly and Company	Score A+	10/10	$1,424	+15.6%	A	View
23	MOH	Molina Healthcare, Inc.	Score A	10/10	$373	+87.8%	C	View
24	SOLV	Solventum Corporation	Score A	10/10	$93	+9.3%	B	View
25	MCK	McKesson Corporation	Score A	10/10	$1,620	+84.1%	C	View
26	MRK	Merck & Co., Inc.	Score A	10/10	$157	+19.7%	B	View
27	PODD	Insulet Corp.	Score A+	10/10	$283	+98.0%	A	View
28	RVTY	Revvity, Inc.	Score A	10/10	$141	+21.8%	C	View
29	REGN	Regeneron Pharmaceuticals, Inc.	Score A+	10/10	$1,171	+44.9%	A	View
30	STE	STERIS plc	Score A	10/10	$276	+15.6%	C	View
31	VRTX	Vertex Pharmaceuticals Incorporated	Score A	10/10	$448	-14.5%	A	View
32	UNH	UnitedHealth Group Incorporated	Score A	10/10	$699	+70.9%	C	View
33	ZTS	Zoetis Inc.	Score A	10/10	$112	+50.0%	A	View
34	ZBH	Zimmer Biomet Holdings, Inc.	Score A	10/10	$129	+32.2%	C	View
35	UHS	Universal Health Services, Inc.	Score A	10/10	$297	+72.1%	B	View
36	NVO	Novo Nordisk A/S	Score B	10/10	$77	+60.7%	A	View
37	NVS	Novartis AG	Score A+	10/10	$295	+88.0%	A	View
38	AZN	AstraZeneca PLC	Score B	10/10	$218	+34.9%	B	View
39	GSK	GSK plc	Score A+	10/10	$68	+30.0%	A	View
40	SNY	Sanofi	Score B	10/10	$61	+39.2%	C	View
41	DOCS	Doximity, Inc.	Score A	10/10	$41	+49.1%	A	View
42	ELV	Elevance Health Inc.	Score A	10/10	$636	+59.9%	C	View
43	ALNY	Alnylam Pharmaceuticals, Inc.	Score A+	10/10	$330	+52.0%	A	View
44	ONC	BeOne Medicines AG	Score A	10/10	$297	-17.3%	B	View
45	MDT	Medtronic plc	Score B	10/10	$120	+33.7%	C	View
46	ARGX	argenx SE	Score A	10/10	$1,259	+45.3%	B	View
47	ISRG	Intuitive Surgical, Inc.	Score C	10/10	$305	-22.5%	A	View
48	RMD	ResMed Inc.	Score A+	10/10	$360	+63.7%	A	View
49	HCA	HCA Healthcare, Inc.	Score A	10/10	$747	+80.5%	B	View
50	AMGN	Amgen Inc.	Score A	10/10	$637	+52.6%	B	View
51	ALGN	Align Technology, Inc.	Score B	9/10	$207	+17.3%	B	View
52	CNC	Centene Corp.	Score D	9/10	$173	+160.0%	F	View
53	DVA	DaVita Inc.	Score B	9/10	$225	+22.6%	D	View
54	CAH	Cardinal Health, Inc.	Score B	9/10	$375	+58.0%	D	View
55	LH	Labcorp Holdings Inc.	Score B	9/10	$536	+66.9%	D	View
56	WST	West Pharmaceutical Services, Inc.	Score B	9/10	$220	-37.6%	A	View
57	MTD	Mettler-Toledo International Inc.	Score B	9/10	$1,209	-15.3%	A	View
58	VTRS	Viatris Inc.	Score B	8/10	$21	+30.0%	D	View
59	BDX	Becton, Dickinson and Company	Score B	8/10	$234	+30.0%	D	View
60	ILMN	Illumina, Inc.	Score A	8/10	$176	-8.2%	C	View
61	HUM	Humana Inc.	Score B	8/10	$377	-2.2%	D	View
62	PFE	Pfizer Inc.	Score A	8/10	$26	-2.7%	C	View
63	TMO	Thermo Fisher Scientific Inc.	Score A	8/10	$530	-11.6%	C	View
64	TECH	Bio-Techne Corporation	Score B	8/10	$38	-46.7%	B	View
65	ALHC	Alignment Healthcare, Inc.	Score D	7/10	$21	+55.1%	F	View
66	ABBV	AbbVie Inc.	Score B	6/10	$208	-15.9%	D	View
67	TEM	Tempus AI, Inc.	Score B (Speculative)	6/10	$89	+61.2%	B	View
68	HIMS	Hims & Hers Health, Inc.	Score A (Speculative)	6/10	$57	+78.1%	B	View
69	CVS	CVS Health Corp.	Score B	5/10	$113	+17.9%	D	View
70	INSM	Insmed Incorporated	Score B (Speculative)	5/10	$170	+26.2%	B	View
71	TFX	Teleflex Incorporated	Score B	4/10	$97	-27.0%	D	View
72	WBA	Walgreens Boots Alliance, Inc.	Score D	4/10	$15	+27.4%	F	View
73	VKTX	Viking Therapeutics, Inc.	Score B (Speculative)	4/10	$46	+33.7%	F	View
74	NTRA	Natera, Inc.	Score B (Speculative)	4/10	$352	+10.5%	A	View
75	OSCR	Oscar Health, Inc.	Score B	4/10	$45	+63.8%	C	View
76	GH	Guardant Health, Inc.	Score B (Speculative)	3/10	$158	-5.6%	C	View
77	ROIV	Roivant Sciences Ltd.	Score B (Speculative)	3/10	$40	+10.1%	C	View
78	SEER	Seer, Inc.	Score D (Speculative)	2/10	$2	+0.0%	D	View
79	CRL	Charles River Laboratories International, Inc.	Score D	1/10	$145	-47.6%	D	View
80	BAX	Baxter International Inc.	Score D (Speculative)	1/10	$19	-32.4%	D	View
81	CTLT	Catalent, Inc.	Score D (Speculative)	1/10	$33	-48.1%	F	View
82	WAT	Waters Corporation	Score D	1/10	$301	-26.9%	D	View
83	MRNA	Moderna, Inc.	Score D (Speculative)	1/10	$32	-45.8%	D	View
84	RVMD	Revolution Medicines, Inc.	Score D (Speculative)	1/10	$120	-42.0%	D	View
85	EXAS	Exact Sciences Corporation	Score D	0/10	$41	-61.2%	D	View

Methodology

Stocks are selected using our 8-step AI conviction framework, which evaluates quality, fair value (PEG, FCF DCF, EV/EBITDA), scenario modeling, and risk/reward asymmetry. The list is updated regularly as new analyses are processed.